Deutsches Herzzentrum Muenchen
tum.deTotal trials
114
Active
11
Phase 3
2
Total enrollment
82,822
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Atrial Fibrillation14
- Coronary Artery Disease12
- Coronary Disease12
- Coronary Heart Disease11
- Myocardial Infarction11
- Acute Coronary Syndrome4
- Electromagnetic Interference3
- Aortic Valve Stenosis3
Frequently asked questions about Deutsches Herzzentrum Muenchen
- How many clinical trials does Deutsches Herzzentrum Muenchen have on ClinicalTrials.gov?
- Deutsches Herzzentrum Muenchen is listed as the lead sponsor on 114 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Deutsches Herzzentrum Muenchen's trials are in Phase 3?
- 2 of Deutsches Herzzentrum Muenchen's trials are in Phase 3.
- What therapeutic areas does Deutsches Herzzentrum Muenchen focus on?
- Deutsches Herzzentrum Muenchen's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Coronary Artery Disease, Coronary Disease, Coronary Heart Disease, Myocardial Infarction.